Baebies' vision is to provide a healthy start for all. We deliver innovative products for newborn screening & pediatric testing powered by digital microfluidics. Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. The test is run on the FINDER® platform, using a 50 µL blood sample (one drop of blood), FINDER delivers results approximately 15 minutes after sample introduction.